MODIFICATION OF SOME RISK FACTORS IN PATIENTS WITH STABLE ANGINA IN TREATMENT WITH BETA-BLOCKERS AND CALCIUM CHANNEL BLOKERS

Similar documents
THE CRITICAL ROLE OF NURSES. Helping patients take control of their LDL-C to lower the risk of MI and stroke.

NUTRITIONAL AND METABOLIC DISEASES CAUSE PREMATURE DEATHS IN BIHOR COUNTY?

Clinical Recommendations: Patients with Periodontitis

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

Treatment of Stable Coronary Artery Disease Pharmacotherapy

ARE YOU AT RISK OF A HEART ATTACK OR STROKE? Understand How Controlling Your Cholesterol Reduces Your Risk

Correlations between Lifestyle and Ischemic Heart Disease in Young Patient

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

ORIGINAL INVESTIGATION. Alcohol Consumption and Mortality in Men With Preexisting Cerebrovascular Disease

Smoking and CVD. .what role for the Cardiologist? Dr Sandeep Gupta, MD, FRCP

Management of Hypertension

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Heart Disease Genesis

Hypertension Management Controversies in the Elderly Patient

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Case Study: Chris Arden. Peripheral Arterial Disease

Non communicable Diseases in Egypt and North Africa

FACTORS OF INFLUENCE OF DEEP VENOUS THROMBOSIS

CARING FOR A LOVED ONE AFTER A HEART ATTACK OR STROKE

cardiovascular risk in elderly people Managing DECISION TO PRESCRIBE keyword: elderlycardio What am I trying to achieve?

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Statistical Fact Sheet Populations

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri

Disclosures. Speaker s bureau: Research grant: Advisory Board: Servier International, Bayer, Merck Serono, Novartis, Boehringer Ingelheim, Lupin

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Healthy Former Drinkers Have Higher Mortality Than Light Drinkers

THE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012

Guidelines on cardiovascular risk assessment and management

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Performance Measure Name: Tobacco Use: Assessing Status after Discharge

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

Understanding Risk Factors for Stroke

Misperceptions still exist that cardiovascular disease is not a real problem for women.

Recent developments in mortality

Angina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room


Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

hypertension Head of prevention and control of CVD disease office Ministry of heath

Structure and organization of blood vessels

Page down (pdf converstion error)

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated

Beta-blockers: Now what? Annemarie Thompson, MD Assistant Professor of Anesthesia and Medicine Vanderbilt University Medical Center

Wine Drinking and Risks of Cardiovascular Complications After Recent Acute Myocardial Infarction

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Update in Hypertension

Treatment to reduce cardiovascular risk: multifactorial management

PNEI NEWS PSYCHE, HEART AND BELLY. Stress, cardiopathies, diabetes, obesity how they are related

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

C-Reactive Protein and Your Heart

Dyslipidemia in women: Who should be treated and how?

Established Risk Factors for Coronary Heart Disease (CHD)

Smoking Cessation: Good News at Last!

the high CVD risk smoker

Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.

Risk Factors for Heart Disease

Antihypertensive Trial Design ALLHAT

Hypertension (JNC-8)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Diabetes and the Heart

Consumption of different types of alcohol and mortality

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

β adrenergic blockade, a renal perspective Prof S O McLigeyo

Decline in CV-Mortality

The Gender Divide Women, Men and Heart Disease February 2017

Cardiovascular Disease

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016

ALLHAT Investigators Report 10-Year Follow-up and Stand by Diuretics as First-Step Antihypertensive Treatment

Guidelines for Integrated Management of. Cardiovascular Diseases and Diabetes. in Clinics and Ri-hospitals

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Low HDL-levels: leave it or treat it?

Disclosures. May 15 th, Influenza Vaccination as Secondary Prevention for Acute Coronary Events Where do we need to go in clinical practice?

Macrovascular Disease in Diabetes

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato

Performance Measure Name: TOB-3 Tobacco Use Treatment Provided or Offered at Discharge TOB-3a Tobacco Use Treatment at Discharge

Executive Summary. Different antihypertensive drugs as first line therapy in patients with essential hypertension 1

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!

PROCORALAN MAKING A STRONG ENTRY TO THE NEW ESC GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

Heart Disease. Signs and Symptoms

Diabetes Mellitus: A Cardiovascular Disease

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

The CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives

Cardiovascular Disease Risk Factors:

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

The New England Journal of Medicine PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE. Population

Living With. Hypertension

The Case for PCI as the Preferred Therapy in Most Patients with Chronic Stable Angina

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Transcription:

Analele UniversităŃii din Oradea, Fascicula Ecotoxicologie, Zootehnie şi Tehnologii de Industrie Alimentară, 2013 MODIFICATION OF SOME RISK FACTORS IN PATIENTS WITH STABLE ANGINA IN TREATMENT WITH BETA-BLOCKERS AND CALCIUM CHANNEL BLOKERS Bei Diana Alina University of Oradea, Faculty of Medicine and Farmacy, 37 Republicii Street, Oradea, Postal Code 410167, România, e-mail: diana_bei@yahoo.com Abstract One of the aims of treatment in stable angina is to improve prognosis by preventing MI and death. A particular attention should be paid to the elements of lifestyle that could have contributed to the condition and which may influence prognosis, including physical activity, smoking, and dietary habits. The study was performed over a period of one year, on a number of of 161 patients with stable angina, with beta-blockers and/or calcium channel blockers in treatment. To each patient was handed a questionnaire that had a series of questions on smoking status, alcohol and coffee consumption and the type of activity performed during the day. This data was calculated statistically and presented in results and discussion results showed that reducing risk factors by improving living conditions (daily stress, inactivity, smoking) was recorded in all groups of study without significant differences between the three groups. Keywords: stable angina, risk factors, INTRODUCTION Over 300 risk factors have been associated with coronary heart disease Some major risks are modifiable in that they can be prevented, treated, and controlled. There are considerable health benefits at all ages, for both men and women, in stopping smoking, reducing cholesterol and blood pressure, eating a healthy diet and increasingphysical activity. Reducing risk factors are the main clinical approach in preventing coronary heart disease mortality and morbidity. Smoking is a major health problem, a major modifiable risk factor for coronary heart disease, risk stratification is based on achieving total consumption of cigarettes and the time of onset of smoking (GăiŃă D., 2007). The risk is significantly higher if smoking onset occurs before the age of 15 years (Ginghină C., 2010, Christakis N.A., J.H. Fowler, 2008). It has been shown that passive smoking increases the risk of coronary heart disease (Ginghină C., 2010, Christakis N.A., J.H. Fowler, 2008, Teo K.K., S. Ôunpuu, S. Hawken, et al. 2006). Smoking acts through several mechanisms atherogenic process, increasing coronary risk by increasing total cholesterol, reduced HDL colesterolululi, increase circulating fibrinogen, increased expression of tissue factor, negative affect endothelial function, platelet aggregation, increased heart rate and blood pressure with skin and coronary vasoconstriction(ginghină C., 2010).Cessation of smoking greatly improves 10

both symptom and prognosis and is an effective method to reduce the risk of acute coronary disease, with immediate benefits to health. Alcohol in moderation may be beneficial but excessive consumption is harmful, especially in patients with hypertension (Pohorecky L.A,1990, Ridker P.M. et al 1994, Sesso H.D et al 2000). It has been difficult to develop public health recommendations on safe limits of alcohol use, but moderate alcohol consumption should not bediscouraged (Critchley J., S. Capewell, 2004, Di Castelnuovo A. et al 2002, Goldberg I.J. et al 2001). Physical activity within the patient s limitations should be encouraged, as it may increase exercise tolerance, reduce symptoms, and has favourable effects on weight, blood lipids, blood pressure, glucose tolerance, and insulin sensitivity. Advice on exercise must take into account the individual s overall fitness and the severity of symptoms. An exercise test can act as a guide to the level at which an exercise programme can be initiated (Fox K., M.A. Garcia, D.Ardisino et al. 2006). Although the role of stress in the genesis of CAD is controversial, there is no doubt that psychological factors are important in provoking attacks of angina. Furthermore, the diagnosis of angina often leads to excessive anxiety. Reasonable reassurance is essential, and patients may benefit from relaxation techniques and other methods of stress control. Appropriate programmes may reduce the need for drugs and surgery(fox K., M.A. Garcia, D.Ardisino et al. 2006). MATERIAL AND METHODS In the present study, 161 pacients of different sex and age between 40-60 years old with stable angina, hospitalized in Emergency County Hospital Oradea, in 2010-2011, were monitored under antianginal treatment. It formed three groups of patients: - the first group including 67 patients age between 50-70 years which were monitored under antinanginal treatment with selective betablockers (Metoprolol 50-100 mg/day, Atenolol 50-100mg/day, Bisoprolol 5-10mg/day); - the second group including 50 patients age between 50-70 years which were monitored under antinanginal treatment with long-acting dihydropyridine calcium-channels blockers (Amlodipin 5-10 mg/day, Lercanidipin 10-20 mg/day, Nifedipin retard 20mg, 40 mg/day); - the third group including 40 patients age between 50-70 years which were monitored under antinanginal selective beta-blockers and longacting dihydropyridine calcium channel blockers in the same time (Metoprolol 50-100 mg + Amlodipin 5-10 mg, Metoprolol 50-100 mg + Lercanidipin 10-20 mg). 11

The general clinical examen and laboratory methods used in the present study were directed to three important aspects: investigate the prognostic, investigate the cardiovascular status, investigate the risk factors in ischemic heart disease. To each patient it was prepared a study sheet which, in addition to identification data, it was included a number of particular elements for structuring and description of study groups. The general protocol concerns the evolution of general living conditions (smoking status, alcohol and coffee consumption, type of physical activity) in the all groups. Statistical analysis was performed using EPIINFO application, version 6.0, program of the Center for Disease Control and Prevention - CDC (Center of Disease Control and Prevention) in Atlanta, adapted processing of medical statistics. RESULTS AND DISCUSSIONS Provided that only statements patients were assessed living conditions, we obtained the following results: first, over 50% of patients were smokers, 20.5% drank alcohol daily and almost 70% of coffee consumed in excess (69.6 %). Inactivity was declared by 62.7% and 84.5% subjection to stress (table 1). The evolution of living conditions for the entire study group Table 1 Living conditions Initially 12 months later Nr. % Nr. % Smoking 81 50,3 68 42,2 Alcohol 33 20,5 29 18,0 Coffee 112 69,6 100 62,1 Sedentarism 101 62,7 94 58,4 Daily stress 136 84,5 131 81,4 After 12 months, 13 patients had quit smoking (16.0% of total smokers), 4 patients dropped daily consumption of alcohol (12.1%) and 12 patients had low coffee consumption (10.7%). Introduction of physical activities in daily life (walking, exercise) was declared the 7 patients (6.9%), and avoiding stress 5 patients (3.7%). Separately analyzing smoking as a risk factor for coronary heart disease, the study results show that 50% of patients were smokers at baseline and after 12 months there was an unsatisfactory rate of 16% who quit smoking (most already having a condition for who quit smoking). Thus, the persistence of the habit of smoking in 42.2% of patients remains a 12

significant factor increased role in accelerating atherogenesis and the development of ischemic heart disease. There are studies that say that smoking may interfere with the effectiveness of drugs, as is the case with beta-blockers and calcium antagonists (Gherasim L.,2004, Zevin S, NL. Benowitz, 1999). Smoking cessation was found in 8.1% of patients, which could have a positive influence on the frequency of episodes of angina, exercise tolerance on exercise test parameters and the final result, the reduction of mortality in these patients (Hortolomei V. D., V.V. Hortolomei, 2011). I noticed a positive aspect of correcting minor sedentary lifestyle, the fact that a percentage of 6.9% chose a more active lifestyle, eliminating this factor predisposing to obesity and subsequently to arteriosclerosis, although its complications. Avoiding stress in 5 patients (3.7%) was recorded because it has great importance in that daily stress and individual personal behavior can often play a decisive role in the development of ischemic heart disease. Reducing risk factors by improving living conditions was recorded in 15 patients, representing 9.3% of the total group. In the group 1, after 12 months, 4 patients had quit smoking (12.5% of total smokers), one patient dropped out daily alcohol consumption (8.3%) and avoided the daily stress (1.7%) and 3 patients declined by coffee consumption (6.3%) and dropped the sedentary (6.7%). Reducing risk factors by improving living conditions was recorded in 5 patients, representing 7.5% of the total group (table 2). In group 2 after 12 months, 4 patients had quit smoking (15.4% of total smokers), one patient dropped daily alcohol consumption (8.3%), and 5 patients had reduced consumption coffee (14.7%) and 2 patients dropped by sedentary (6.7%) have reduced daily stress (4.9%). Reducing risk factors by improving living conditions was recorded in 5 patients, representing 10.0% of the total group (table 2). In the group 3 after 12 months, 5 patients had quit smoking (21.7% of total smokers), 2 patients dropped by daily consumption of alcohol (22.2%) dropped the sedentary (7.7%) and reduced daily stress (5.4%), and 4 patients dropped excesiv coffee consumption (13.3%). Reducing risk factors by improving living conditions was recorded in 5 patients, representing 11.4% of the total group(table 2). Both at initial assessment and at the end, there were no significant differences between the 3 groups in terms of living conditions (p = 0.625 and p = 0.451). 13

The evolution of living conditions compared between groups Living conditions Group 1 Group 2 Group 3 Initially Smoking 32 47,8 26 52,0 23 52,3 Alcohol 12 17,9 12 24,0 9 20,5 Coffee 48 71,6 34 68,0 30 68,2 Sedentarism 45 67,2 30 60,0 26 59,1 Stres cotidian 58 86,6 41 82,0 37 84,1 12 month later Smoking 28 41,8 22 44,0 18 40,9 Alcohol 11 16,4 11 22,0 7 15,9 Coffe 45 67,2 29 58,0 26 59,1 Sedentarism 42 62,7 28 56,0 24 54,5 Stres cotidian 57 85,1 39 78,0 35 79,5 Table 2 CONCLUSIONS Reducing risk factors by improving living conditions (daily stress, inactivity, smoking) was recorded in all groups of study without significant differences between the three groups. Moving forward in small consecutive steps is one of the key points in long-term behavior change. REFERENCES 1. Christakis N.A., J.H. Fowler, 2008, The collective dynamics of smoking in a large social network. N Engl J Med ; 358: 2249-58; 2. Critchley J., S. Capewell, 2004, Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev.; (1): CD003041 3. Di Castelnuovo A., S. Rotondo, L. Iacoviello, M.B., Donati, G. De Gaetano, 2002, Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation;105:2836 2844. 4. Fox K., M.A. Garcia, D.Ardisino et al. 2006, The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris. Full text. European Heart Journal; 5. GăiŃă D., 2007, Optimizarea stilului de viańă în prevenńia cardiovasculară de la ghiduri actuale la practica clinică, Progrese în Cardiologie volum II,Editura :Media Med Publicis:361-381; 6. Ginghină C.,2010 Mic tratat de cardiologie, Ed. Academiei Române 7. Gherasim L., 2004, Angina pectorală. Bolile cardiovasculare şi metabolice. Medicină Internă. EdiŃia a-2-a revizuită, Ed. Medicală, partea I; pp:767-822 8. Goldberg I.J., L. Mosca, M.R. Piano, E.A. Fisher, 2001, AHA Science Advisory: Wine and your heart: a science advisory for healthcare professionals from the 14

Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association.Circulation;103:472 475 9. Hortolomei V. D., V.V. Hortolomei, 2011, Cardiopatia ischemică la persoanele vârstnice, Curierul medical, nr. 3(327):215-220; 10. Pohorecky L.A,1990, Interaction of alcohol and stress at the cardiovascular level. Alcohol 7 (6): 537; 11. Ridker P.M., D.E. Vaughan, M.J. Stampfer, R.J. Glynn, C.H. Hennekens, 1994, Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 272:929-933; 12. Sesso H.D., M.J. Stampfer, B. Rosner, C.H. Hennekens, J.E. Manson, J.M. Gaziano, 2000, 7 year changes in alcohol consumption and subsequent risk of cardiovascular disease in men. Arch Intern Med ;160:2605 2612. 13. Teo K.K., S. Ôunpuu, S. Hawken, et al. 2006, Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet; 368: 647-58; 14. Zevin S, NL. Benowitz, 1999, Drug interactions with tobacco smoking. Clin. Pharmacokinet., 36:425 438; 15